Sepp-Lorenzino Laura

EVP, Chief Scientific Officer at NTLA

Sold, on record
$19.3M
Dollars the filings state
Form 4 sales
7
Latest Jan 3, 2025
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NTLAIntellia Therapeutics, Inc.EVP, Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NTLAUnusual
    Aug 4, 2021 2021

    Sold 26,000 shares at $138.24 ($3.6M)

    Sepp-Lorenzino Laura, EVP, Chief Scientific Officer

    Sold 91.6% of holdings ($3.9M position)2,391 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NTLAUnusual
    Aug 30, 2021 +26 days

    Sold 97,000 shares at $154.83 ($15M)

    Sepp-Lorenzino Laura, EVP, Chief Scientific Officer

    Sold 97.6% of holdings ($15.4M position)2,391 shares leftFiling

  3. 3 Form 4 sale NTLAPlan not stated
    Jan 1, 2022 +124 days

    Sold 1,148 shares at $112.25 ($129k)

    Sepp-Lorenzino Laura, EVP, Chief Scientific Officer

    Sold 19.3% of holdings ($669k position)4,815 shares leftFiling

  4. 4 Form 4 sale NTLAPlan not stated
    Jan 5, 2023 +369 days

    Sold 4,838 shares at $37.82 ($183k)

    Sepp-Lorenzino Laura, EVP, Chief Scientific Officer

    Sold 21.5% of holdings ($850k position)17,629 shares left0.2x usual sizeFiling

  5. 5 Form 4 sale NTLANo plan
    Jan 3, 2024 +363 days

    Sold 5,532 shares at $29.46 ($163k)

    Sepp-Lorenzino Laura, EVP, Chief Scientific Officer

    No 10b5-1 planSold 10.7% of holdings ($1.5M position)46,202 shares leftFiling

  6. 6 Form 144 notice NTLANotice
    Jan 8, 2024 +5 days

    Filed to sell 2,275 shares ($64k)

    Sepp-Lorenzino Laura, Officer

    10b5-1 planFiling

  7. 7 Form 4 sale NTLARoutine
    Jan 8, 2024 same day

    Sold 2,275 shares at $28.87 ($66k)

    Sepp-Lorenzino Laura, EVP, Chief Scientific Officer

    10b5-1 planSold 4.9% of holdings ($1.3M position)43,927 shares leftFollows a Form 144Filing

  8. 8 Form 4 sale NTLANo plan
    Jan 3, 2025 +361 days

    Sold 8,966 shares at $12.18 ($109k)

    Sepp-Lorenzino Laura, EVP, Chief Scientific Officer

    No 10b5-1 planSold 10.4% of holdings ($1.1M position)77,388 shares left1.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Sepp-Lorenzino Laura
Source
Jan 3, 2025Jan 7, 2025NTLAEVP, Chief Scientific OfficerForm 4 sale8,966$109k10.4%No planSEC
Jan 8, 2024Jan 10, 2024NTLAEVP, Chief Scientific OfficerForm 4 sale2,275$66k4.9%RoutineSEC
Jan 8, 2024Jan 8, 2024NTLAOfficerForm 144 notice2,275$64kNoticeSEC
Jan 3, 2024Jan 5, 2024NTLAEVP, Chief Scientific OfficerForm 4 sale5,532$163k10.7%No planSEC
Jan 5, 2023Jan 6, 2023NTLAEVP, Chief Scientific OfficerForm 4 sale4,838$183k21.5%Plan not statedSEC
Jan 1, 2022Mar 3, 2022NTLAEVP, Chief Scientific OfficerForm 4 sale1,148$129k19.3%Plan not statedSEC
Aug 30, 2021Sep 1, 2021NTLAEVP, Chief Scientific OfficerForm 4 sale97,000$15M97.6%UnusualSEC
Aug 4, 2021Aug 6, 2021NTLAEVP, Chief Scientific OfficerForm 4 sale26,000$3.6M91.6%UnusualSEC